Extract

We read with great interest the European Respiratory Society (ERS) guidelines for pulmonary alveolar proteinosis (PAP) by McCarthy et al. [1], which were recently published in the European Respiratory Journal. The task force's recommendations addressed many important questions on the role and hierarchical steps in diagnostic testing and treatment of patients with suspected and diagnosed PAP. We would like to commend the authors on this collaborative and important work, while highlighting some of the challenges that remain in the management of this rare and often life-threatening syndrome.

中文翻译：

---

关于欧洲呼吸学会肺泡蛋白沉积症指南的评论

 提取

我们饶有兴趣地阅读了 McCarthy等人的欧洲呼吸学会 （ERS） 肺泡蛋白沉积症 （PAP） 指南。[1]，该研究最近发表在《欧洲呼吸杂志》上。该工作组的建议解决了许多关于疑似和确诊 PAP 患者诊断检测和治疗中的作用和分层步骤的重要问题。我们要赞扬作者在这项合作和重要工作中的工作，同时强调在管理这种罕见且通常危及生命的综合征方面仍然存在的一些挑战。